Journalism of Courage
Advertisement
Prabha Raghavan
Authors you can follow
More From Prabha Raghavan - Page 8
Harley-Davidson exit may push auto tariff cut up in US priority list for limited trade dealSubscriber Only
September 28, 2020 03:09 IST
Over the last three years, several US car and motorcycle firms, including General Motors, Ford Motor Co and Cleveland CycleWerks have either restructured operations to exist as joint ventures or exited the Indian market altogether.
Mon, Sep 28, 2020
Harley-Davidson, Trump’s sticking point over ‘high tariffs’, to ride out of IndiaSubscriber Only
September 25, 2020 01:27 IST
There is a possibility this exit will be used by the US to push for a further revision in India’s tariffs on goods such as top-end motorcycles, given that the tariff barrier did not sustain Harley-Davidson’s Make in India efforts, said a trade analyst on condition of anonymity.
Fri, Sep 25, 2020
Bharat Biotech exploring global tie-ups for Covaxin manufacturingSubscriber Only
September 24, 2020 07:47 IST
“In the month of October, we plan to start our phase 3 clinical trials,” said Sai D Prasad, President-Quality Operations, Bharat Biotech, during the Virtual Expo on Pharma, Healthcare, Diagnostics and Hygiene on Wednesday.
Thu, Sep 24, 2020
How nasal vaccines for Covid-19 work: utility and concernsSubscriber Only
September 24, 2020 03:48 IST
Intranasal vaccines are also expected to cut down on the dependence on various trained personnel to administer the vaccine, according to experts.
Sat, Sep 26, 2020
Bharat Biotech to make a billion doses of an intranasal adenovirus vaccineSubscriber Only
September 23, 2020 12:27 IST
The agreement is expected to help overcome potential difficulties with distributing the vaccine, like the high cost of vaccination or a possible shortage of personnel to administer the doses to the required population.
Thu, Sep 24, 2020
‘Covid vaccine should better clinical results by at least 50% for approval’Subscriber Only
September 23, 2020 03:05 IST
The regulator, which released a new set of guidelines for Covid-19 vaccines on Monday, also emphasized that the statistical range of efficacy (the ability to produce the desired outcome) in the human trials cannot be lower than 30 per cent.
Wed, Sep 23, 2020
Explained: Efficacy in 50% cases and other draft guidelines for Covid-19 vaccines approvalSubscriber Only
September 22, 2020 15:09 IST
India's top drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has released a set of draft regulatory guidelines for Covid-19 vaccines. What do they say?
Wed, Sep 23, 2020
Dr Reddy’s-Russia Sputnik V deal: Can India get a coronavirus vaccine this year?Subscriber Only
September 17, 2020 16:17 IST
India Coronavirus (Covid-19) vaccine: Should India’s top drug regulatory body sign off on phase 3 trials in the country, Sputnik V will replace Serum Institute of India’s (SII's) ‘Covishield’ as the frontrunner in the race to produce a Covid-19 vaccine for India.
Sun, Sep 27, 2020
Dr Reddy’s inks deal to distribute 100 mn doses of Sputnik VSubscriber Only
September 17, 2020 01:27 IST
This is the first concrete development on Sputnik V after the Indian government confirmed it was in discussions to take forward the testing and manufacture of the candidate, which Russia approved for public use last month.
Thu, Sep 17, 2020
Dr Reddy’s to conduct phase 3 trials for Russia’s Sputnik V Covid-19 vaccine in IndiaSubscriber Only
September 16, 2020 15:53 IST
This is the first concrete development on the Sputnik V front since India confirmed it was in discussions to take forward the testing and manufacture of the vaccine candidate that Russia cleared for public use last month.
Wed, Sep 16, 2020
Indian Immunologicals in talks to manufacture Russia’s Sputnik V; ‘lot of parameters to consider’Subscriber Only
September 16, 2020 03:05 IST
The talks, still not finalised, involve an exchange of information on both sides to ascertain whether the Hyderabad-headquartered firm can successfully incorporate the Russian technology and scale up production here.
Wed, Sep 16, 2020
Draft NDHM policy: Experts warn of ‘structural problems’, lack of clarity on patient control over dataSubscriber Only
September 14, 2020 03:41 IST
The policy puts the onus on the individual to understand whether they should consent to giving their data, but there is no clarity on whether it will be in a format that is easy to understand.
Mon, Sep 14, 2020
Vaccine trials in UK to resume: AstraZenecaSubscriber Only
September 13, 2020 01:14 IST
The company said it will continue to work with health authorities “across the world” and will “be guided” as to when other clinical trials can resume.
Sun, Sep 13, 2020
Days after halt, AstraZeneca says UK trials for Covid-19 vaccine to resumeSubscriber Only
September 12, 2020 20:34 IST
The company said it will continue to work with health authorities “across the world” and “be guided” as to when other clinical trials can resume.
Sat, Sep 12, 2020
Oxford-AstraZeneca Covid-19 vaccine trials paused: Why this may not be a serious blowSubscriber Only
September 11, 2020 18:07 IST
Given the fact that the same vaccine is being tested globally and in India, it is important to ensure that there is no possibility of a similar incident occuring in participants here – especially since the number of volunteers in India is much less than the 5,000-10,000 who have been vaccinated in other countries.
Wed, Sep 16, 2020
Day after regulator notice, Serum says pausing Oxford vaccine India trialsSubscriber Only
September 11, 2020 03:27 IST
The trials were halted by AstraZeneca after one participant, who reportedly took part in the phase 2/3 clinical trials underway in the United Kingdom, developed a "potentially unexplained illness".
Fri, Sep 11, 2020
Oxford vaccine trial paused after adverse event; India testing won’t be hit: SerumSubscriber Only
September 10, 2020 02:28 IST
The adverse event seen in the UK case has not been noted in any of the Indian participants so far. However, it is likely to be taken up by a safety expert group which will review information collected from the first set of participants in the human clinical trials in India.
Thu, Sep 10, 2020
Explained: What Oxford-AstraZeneca Covid-19 vaccine trial pause means for trialsSubscriber Only
September 10, 2020 01:02 IST
Oxford-AstraZeneca Coronavirus Vaccine: Trials of Oxford-AstraZeneca’s Covid-19 vaccine have been paused, reportedly after severe adverse reaction in a participant in England. What happens to the India trials? Why do some see it as a blessing in disguise?
Wed, Sep 16, 2020
Indian Covid-19 vaccine: At what stage are under-trial coronavirus vaccine candidates?Subscriber Only
September 08, 2020 03:52 IST
India coronavirus (Covid-19) vaccine: With several announcements of companies either entering into agreements to make Covid-19 vaccines or announcing human clinical trials for their candidates in India in the last few months, The Indian Express recaps the major players to watch out for here now
Sun, Sep 13, 2020
Punjab: Amid unprecedented demand, tocilizumab supply dries upSubscriber Only
September 07, 2020 04:30 IST
Several facilities have been prescribing the drug to mitigate ‘cytokine storm’, which could cause life threatening inflammation in Covid-19 patients.
Mon, Sep 07, 2020
Uttar Pradesh jumps 10 places to rank second in ease of doing businessSubscriber Only
September 06, 2020 04:50 IST
Odisha to protest rankings; user feedback new factor
Sun, Sep 06, 2020
‘Though we may seem behind, we are going to catch up quickly… Biological E can make a billion doses of the vaccine’Subscriber Only
September 04, 2020 06:06 IST
In an interview to The Indian Express, Dr Maria Elena Bottazzi explains how the facility was able to speed up development of this vaccine and how the tie-up with the Hyderabad-headquartered vaccine maker can help scale up production of an affordable Covid-19 vaccine.
Sat, Sep 05, 2020
India among worst hit major economies globally; local lockdowns added to woesSubscriber Only
September 01, 2020 01:18 IST
While China, which many believe to be the epicentre of the Covid-19 outbreak, announced a surprise 3.2 per cent growth in its GDP during this quarter compared to the same period last year, others like the UK and Germany witnessed a contraction.
Tue, Sep 01, 2020
Explained: Changes in CSR rules that benefit companies working on Covid-19 curesSubscriber Only
August 25, 2020 17:31 IST
Firms engaged in "research and development activity of new vaccine, drugs and medical devices in their normal course of business" will be eligible for CSR benefits.
Wed, Aug 26, 2020
Delivery mechanism: Waiting for vaccine, key players knock on India’s door for vials and syringesSubscriber Only
August 24, 2020 03:59 IST
India has the capacity to manufacture “more than” 2 billion units of these vials, according to industry sources.
Mon, Aug 24, 2020Journalism of Courage
Install the Express App for
a better experience
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us